|
Take heed to this text  |
Siemens Healthineers introduced its Corindus firm rebranded to “Siemens Healthineers Endovascular Robotics.”
In 2019, Siemens Healthineers acquired Corindus for $1.1 billion. Corindus develops the CorPath robot-assisted system for coronary and peripheral vascular procedures.
In keeping with Siemens, model unification represents “the ultimate step” within the firm integration course of that started in 2019. The enterprise goals to advance interventions with robotics, altering the supply of care by way of improvements. These improvements improve doctor methods and produce precision to interventional procedures, Siemens mentioned.
Siemens mentioned it now affords the Endovascular Robotics enterprise entry to its company-wide assets. That permits it to proceed advancing its imaginative and prescient of growing image-guided robotic options. It intends to proceed providing the CorPath GRX system to assist endovascular procedures.
All Corindus channels, together with its web site and social media profiles, will formally shut down on Dec. 16, 2022. Siemens plans to make all supplies beforehand shared on the Corindus web site out there by itself. The general rebranding transition stays underway.
“The completion of our model evolution marks the ultimate step to turning into a united firm and we stay targeted on pioneering breakthroughs for everybody, in every single place,” mentioned Wayne Markowitz, worldwide EVP of Siemens Healthineers and head of Endovascular Robotics. “Our flagship product, the CorPath GRX System, is designed to assist endovascular interventions, and we sit up for working with our prospects as Siemens Healthineers Endovascular Robotics whereas fueling our imaginative and prescient to attach extra sufferers to superior care.”
Editor’s Notice: This text first seem on sister publication MassDevice and was reprinted with permission.
